[HTML][HTML] On the genetics of retinitis pigmentosa and on mutation‐independent approaches to therapeutic intervention

GJ Farrar, PF Kenna, P Humphries - The EMBO journal, 2002 - embopress.org
Retinitis pigmentosa (RP), the group of hereditary conditions involving death of retinal
photoreceptors, represents the most prevalent cause of visual handicap among working …

On the molecular genetics of retinitis pigmentosa

P Humphries, P Kenna, GJ Farrar - Science, 1992 - science.org
The human retina carries specialized neurons, the rod and cone photoreceptors, which
absorb and transduce light energy and transmit impulses through the optic nerve to the …

NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components

SL Doyle, M Campbell, E Ozaki, RG Salomon, A Mori… - Nature medicine, 2012 - nature.com
Age-related macular degeneration (AMD) is the leading cause of central vision loss
worldwide. Drusen accumulation is the major pathological hallmark common to both dry and …

Retinopathy induced in mice by targeted disruption of the rhodopsin gene

MM Humphries, D Rancourt, GJ Farrar, P Kenna… - Nature …, 1997 - nature.com
Retinitis pigmentosa (RP) represents the most common mendelian degenerative retinopathy
of man, involving death of rod photoreceptors, cone cell degeneration, retinal vessel …

Toward an elucidation of the molecular genetics of inherited retinal degenerations

GJ Farrar, M Carrigan, A Dockery… - Human molecular …, 2017 - academic.oup.com
While individually classed as rare diseases, hereditary retinal degenerations (IRDs) are the
major cause of registered visual handicap in the developed world. Given their hereditary …

A three-base-pair deletion in the peripherin–RDS gene in one form of retinitis pigmentosa

GJ Farrar, P Kenna, SA Jordan, R Kumar-Singh… - Nature, 1991 - nature.com
THE group of retinopathies termed retinitis pigmentosa (RP) greatly contribute to visual
dysfunction in man with a frequency of roughly 1 in 4,000 (refs 1, 2). We mapped the first …

Effective delivery of large genes to the retina by dual AAV vectors

I Trapani, P Colella, A Sommella, C Iodice… - EMBO molecular …, 2014 - embopress.org
Retinal gene therapy with adeno‐associated viral (AAV) vectors is safe and effective in
humans. However, AAV's limited cargo capacity prevents its application to therapies of …

[HTML][HTML] A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement

SJ Bowne, MM Humphries, LS Sullivan… - European journal of …, 2011 - nature.com
Linkage testing using Affymetrix 6.0 SNP Arrays mapped the disease locus in TCD-G, an
Irish family with autosomal dominant retinitis pigmentosa (adRP), to an 8.8 Mb region on …

[HTML][HTML] Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa

S Millington-Ward, N Chadderton, M O'reilly, A Palfi… - Molecular therapy, 2011 - cell.com
For dominantly inherited disorders development of gene therapies, targeting the primary
genetic lesion has been impeded by mutational heterogeneity. An example is rhodopsin …

[PDF][PDF] RNA interference–mediated suppression and replacement of human rhodopsin in vivo

M O'Reilly, A Palfi, N Chadderton… - The American Journal of …, 2007 - cell.com
Mutational heterogeneity represents a significant barrier to development of therapies for
many dominantly inherited diseases. For example,> 100 mutations in the rhodopsin gene …